Skip to Content

Join the 'Cancer' group to help and get support from people like you.

Cancer News

Related terms: Carcinoma, Malignant Disease, Malignant Tumor

McCain Says No to Latest Effort to Replace Obamacare

Posted 11 hours ago by Drugs.com

FRIDAY, Sept. 22, 2017 – Sen. John McCain dealt a body blow to the latest effort to replace Obamacare on Friday by announcing that he can't vote for the Graham-Cassidy health care bill as it stands. "I believe we could do better working together, Republicans and Democrats, and have not yet really tried," McCain (R-Ariz.) said in a statement. "Nor could I support it without knowing how much it will cost, how it will affect insurance premiums, and how many people will be helped or hurt by it." "Without a full CBO [Congressional Budget Office] score, which won't be available by the end of the month, we won't have reliable answers to any of those questions," McCain noted. Meanwhile, Sen. Susan Collins (R-Maine) said Friday that she is leaning toward voting no on the bill, while Sen. Rand Paul (R-Ky.) has already voiced his opposition to the latest proposal. If all three vote no, the bill ... Read more

Related support groups: Cancer, Prevention of Cardiovascular Disease, Cardiovascular Risk Reduction

Survey: 9 of 10 Americans Take Cancer Prevention Steps

Posted 15 hours ago by Drugs.com

FRIDAY, Sept. 22, 2017 – About 95 percent of Americans take some action to prevent cancer, according to a new survey. Three-quarters of respondents said they don't smoke; 74 percent limit their alcohol consumption; 72 percent stick to a healthy diet; and 90 percent are aware of their family's cancer history, the survey found. Women are far more likely than men to take all three preventive steps and more – discussing risk and prevention with their health care provider, getting the recommended amount of sleep, and undergoing recommended cancer screenings. The fourth edition of the Mayo Clinic National Health Checkup also reported that 62 percent said they or a loved one had been diagnosed with cancer. Sixty-one percent are concerned that they will develop cancer during their lifetime. Despite the concern, many respondents have an optimistic attitude: 78 percent expect a cure for cancer ... Read more

Related support groups: Cancer, Smoking, Breast Cancer, Smoking Cessation, Lung Cancer, Colorectal Cancer

Inflammatory Bowel Disease May Raise Cancer Risk in Kids

Posted 1 day 15 hours ago by Drugs.com

THURSDAY, Sept. 21, 2017 – Children with inflammatory bowel disease (IBD) face an increased risk of cancer, a new study claims. The risk persists into adulthood, and is especially elevated for gastrointestinal cancers, the researchers added. The "extent and duration of chronic inflammation might be the main driving mechanisms underlying the increased risk of cancer," the researchers suggested. The international team, led by Dr. Ola Olen, a pediatric gastroenterologist at Karolinska Institute in Stockholm, compared about 9,400 patients in Sweden who were diagnosed with IBD before age 18 to a control group of nearly 93,000 people without IBD. The risk of cancer up to an average age of 30 was 3.3 cases per 1,000 person years among those with IBD. That compared with 1.5 cases per 1,000 person years in the control group. So, the overall risk of cancer among people with IBD is still low, the ... Read more

Related support groups: Cancer, Crohn's Disease, Colitis, Ulcerative Colitis, Crohn's Disease - Maintenance, Colorectal Cancer, Inflammatory Bowel Disease, Ulcerative Colitis - Active, Crohn's Disease - Acute, Ulcerative Colitis - Maintenance, Lymphocytic Colitis, Pseudomembranous Colitis, Noninfectious Colitis, Enterocolitis, Allergic Colitis

Health Tip: Medication Suggestions for Older Adults

Posted 3 days ago by Drugs.com

-- It may be difficult and confusing for older adults to manage an ever-growing list of medications and supplements. The U.S. Food and Drug Administration suggests: Take only medications and supplements recommended by your doctor. Keep a medication and supplement list, and share this information with all doctors and caregivers. Be aware of potential drug/supplement interactions and side effects. If you have a question or are unsure, ask your doctor. Review all medications and supplements with your doctor at your annual physical. Read more

Related support groups: Cancer, Prevention of Cardiovascular Disease, Cardiovascular Risk Reduction

Cancer Treatment Can Affect Your Food Preferences

Posted 3 days ago by Drugs.com

TUESDAY, Sept. 19, 2017 – Cancer therapies often change patients' sense of taste, which may affect what they like to eat, according to a nutrition expert. "Increased taste sensitivities are more common than a muting of taste," said Catherine Carpenter, professor of clinical nutrition at UCLA's David Geffen School of Medicine. "Usually, the type of taste sensitivity encountered is one of a metallic nature." Changes in tastes often influence a person's food preferences, but treatment may affect individuals differently, Carpenter noted in a university news release. "If anything, patients tend to prefer bland foods rather than spicy foods," she said. "It's important to remember that preferences may vary depending on the cancer and type of treatment. You cannot lump all cancer patients into one dietary regimen." After treatments, such as chemo or radiation therapy, a nutritionist can help ... Read more

Related support groups: Cancer, Methotrexate, Breast Cancer, Oral and Dental Conditions, Xerostomia, Fluorouracil, Colorectal Cancer, Xeloda, Nausea/Vomiting - Chemotherapy Induced, Hydroxyurea, Mercaptopurine, Hydrea, Capecitabine, Dacogen, Gemzar, Gemcitabine, Alimta, Decitabine, Cladribine, Folotyn

FDA Approves Mvasi (bevacizumab-awwb), a Biosimilar to Avastin

Posted 5 days ago by Drugs.com

September 14, 2017 – The U.S. Food and Drug Administration today approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple types of cancer. Mvasi is the first biosimilar approved in the U.S. for the treatment of cancer. “Bringing new biosimilars to patients, especially for diseases where the cost of existing treatments can be high, is an important way to help spur competition that can lower healthcare costs and increase access to important therapies,” said FDA Commissioner Scott Gottlieb, M.D. “We’ll continue to work hard to ensure that biosimilar medications are brought to the market quickly, through a process that makes certain that these new medicines meet the FDA’s rigorous gold standard for safety and effectiveness.” Mvasi is approved for the treatment of adult patients with certain colorectal, lung, brain, kidney and cervical cancers ... Read more

Related support groups: Cancer, Lung Cancer, Colorectal Cancer, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Avastin, Cervical Cancer, Glioblastoma Multiforme, Bevacizumab, Mvasi

Nearly 25 Million U.S. Workers Now Have High-Deductible Health Plans

Posted 8 days ago by Drugs.com

FRIDAY, Sept. 15, 2017 – The number of American workers with high-deductible health insurance plans rose by 3.2 percent in 2016 – reaching 24.8 million, new research reports. While premium prices rose modestly for people with employer-provided coverage, their deductibles rose 10 percent on average, University of Minnesota researchers found. "High-deductible health plans are increasingly becoming the norm in commercial insurance, and there is every reason to expect this trend to continue," said Katherine Hempstead, senior advisor at the Robert Wood Johnson Foundation. The foundation funded the study. For the study, researchers analyzed national data and found more than 58 million American workers were enrolled in an employer-sponsored insurance plan in 2016. The average deductible was $1,696 for single plans, a 10.1 percent increase from 2015. The increases averaged $155, the study ... Read more

Related support groups: Cancer, Prevention of Cardiovascular Disease, Cardiovascular Risk Reduction

Mvasi Is First Biosimilar Drug Approved for Cancer

Posted 8 days ago by Drugs.com

THURSDAY, Sept. 14, 2017 – The first biosimilar drug to treat cancer has been approved by the U.S. Food and Drug Administration. Mvasi (bevacizumab-awwb) was found to be biosimilar to the anti-cancer drug Avastin, the FDA said Thursday in a news release. Avastin was approved in 2004. Biosimilar drugs are typically derived from living organisms and are approved after manufacturers demonstrate that the medications are "highly similar" to already approved drugs, the agency said. Mvasi is approved to treat certain cancers of the colon, lung, brain, kidney and cervix, the FDA said. "Bringing new biosimilars to patients, especially for diseases where the cost of existing treatments can be high, is an important way to help spur competition that can lower healthcare costs and increase access to important therapies," said FDA Commissioner Dr. Scott Gottlieb. He pledged new biosimilar drugs ... Read more

Related support groups: Cancer, Lung Cancer, Colorectal Cancer, Avastin, Cervical Cancer, Bevacizumab, Mvasi

FDA OKs First 'Biosimilar' Drug to Fight Cancer

Posted 9 days ago by Drugs.com

THURSDAY, Sept. 14, 2017 – The first approval of a biosimilar drug to treat cancer was announced Thursday by the U.S. Food and Drug Administration. Mvasi (bevacizumab-awwb) was approved as a biosimilar to Avastin (bevacizumab) for the treatment of adults with certain colon, lung, brain, kidney and cervical cancers. A biosimilar is a biological product that is approved because it is highly similar to an already-approved biologic drug and has no significant differences in safety and effectiveness from the first product, the FDA explained. "Bringing new biosimilars to patients, especially for diseases where the cost of existing treatments can be high, is an important way to help spur competition that can lower health care costs and increase access to important therapies," FDA Commissioner Dr. Scott Gottlieb said in an agency news release. Mvasi is marketed by Amgen, Inc., headquartered in ... Read more

Related support groups: Cancer, Lung Cancer, Colorectal Cancer, Renal Cell Carcinoma, Brain Tumor, Avastin, Cervical Cancer, Bevacizumab, Mvasi

Republicans Take Another Run at Obamacare Overhaul

Posted 9 days ago by Drugs.com

THURSDAY, Sept. 14, 2017 – Senate Republicans on Wednesday introduced a plan to roll back key provisions of the Affordable Care Act and use that money to provide block grants to states. It's widely seen as a last-ditch attempt by the GOP to fulfill its vow to replace the health reform law often called Obamacare. Republicans in the Senate only have until Sept. 30 to pass a repeal-and-replace bill under "budget reconciliation" rules that waive the usual 60-vote threshold in the Senate, Timothy Jost, emeritus law professor at Washington and Lee University, said Wednesday in a Health Affairs blog. The bill sponsored by Senators Lindsey Graham of South Carolina, Bill Cassidy of Louisiana, Dean Heller of Nevada and Ron Johnson of Wisconsin would give states more decision-making authority on how to allocate health care dollars. On MSNBC's "Morning Joe" on Thursday, Cassidy said Republican and ... Read more

Related support groups: Cancer, Prevention of Cardiovascular Disease, Cardiovascular Risk Reduction

U.S. Cancer Death Rate Continues to Fall

Posted 9 days ago by Drugs.com

THURSDAY, Sept. 14, 2017 – More Americans are surviving cancer than ever before, but as the population ages, even more will develop the disease. That's the good and bad news from the 2017 Cancer Progress Report from the American Association for Cancer Research, released Wednesday. According to the report, the cancer death rate dropped 35 percent among children and 25 percent among adults from 1991 to 2014. That translates to slightly more than 2 million fewer cancer deaths. On the flip side, new cancer diagnoses are predicted to rise from nearly 1.7 million this year to 2.3 million in 2030, said the association's president, Dr. Michael Caligiuri. And this year alone, more than 600,000 Americans are predicted to die from cancer, according to the report. Caligiuri said the increase in cancer cases is simply a consequence of more people living longer. As the report noted, 53 percent of ... Read more

Related support groups: Cancer, Smoking, Smoking Cessation, Gardasil, Human Papillomavirus Vaccine, Cervarix, Human Papillomavirus Prophylaxis, Vaccination and Prophlaxis, Gardasil 9

Widening Waistlines May Raise Women's Cancer Risk

Posted 10 days ago by Drugs.com

TUESDAY, Sept. 12, 2017 – Excess belly fat increases older women's risk of some cancers, new research suggests. Researchers followed nearly 5,900 Danish postmenopausal women for up to 12 years and found that abdominal fat was a bigger factor than body weight when it came to the risk of lung and gastrointestinal cancers. The study was presented Sept. 10 at a European Society for Medical Oncology meeting, in Madrid, Spain. The findings highlight the need for weight management priorities for older women, who are prone to abdominal weight gain, according to study author Line Maersk Staunstrup, a doctoral student at Nordic Bioscience ProScion in Denmark. "The average elderly women can very much use this information, as it is known that the menopause transition initiates a shift in body fat towards the central trunk area. Therefore elderly women should be especially aware of their lifestyle ... Read more

Related support groups: Obesity, Cancer, Metformin, Weight Loss, Glucophage, Janumet, Glucophage XR, ActoPlus Met, Glumetza, Janumet XR, Glyburide/Metformin, Glucovance, Jentadueto, Avandamet, Glipizide/Metformin, Metformin/Pioglitazone, Fortamet, Kombiglyze XR, Xigduo XR, Riomet

Many May Get Hospice Care Too Late

Posted 10 days ago by Drugs.com

TUESDAY, Sept. 12, 2017 – Despite a growing list of debilitating symptoms during the final months of life, most seniors never receive end-of-life hospice care – or they delay doing so until their last few weeks of life, new research finds. "The main message is that the duration of hospice is very short," explained lead study author Dr. Thomas Gill. This, despite the fact that his team "documented high rates of distressing symptoms well before the start of hospice." Gill is the director of the Yale University Program on Aging. "Since hospice is designed to help alleviate distressing symptoms – including pain, nausea and anxiety, among others – our findings suggest that health care providers might need to consider discussing referrals to hospice sooner with older persons who are approaching the end of their lives," Gill added. The National Hospice and Palliative Care Organization ... Read more

Related support groups: Cancer, Breast Cancer, Dementia, Prostate Cancer, Alzheimer's Disease, Lung Cancer, Colorectal Cancer, Mild Cognitive Impairment, Solid Tumors, Lewy Body Dementia

Cancer Drugs' High Prices Not Justified by Cost of Development, Study Contends

Posted 11 days ago by Drugs.com

TUESDAY, Sept. 12, 2017 – Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs. But a new analysis, focused on 10 new cancer drugs, finds those costs may have been greatly exaggerated – and the return on investment for drug companies is lucrative indeed. The study found that the typical R&D process for a new cancer medication spans about seven years, with an average per-drug cost of between $648 million and $794 million. Pricey, yes – but still far below the $2.7 billion-per-drug R&D figure determined by a 2016 Tufts University investigation. It's that number that drug companies have pointed to as their average R&D cost per drug. And the pay-off, once a new cancer drug reaches the market, can be enormous, the new study found. According to the researchers, after an average of about four years on ... Read more

Related support groups: Cancer, Imbruvica, Xtandi, Ibrutinib, Jakafi, Ruxolitinib, Soliris, Adcetris, Cabometyx, Folotyn, Cabozantinib, Brentuximab, Cometriq, Iclusig, Eculizumab, Ponatinib, Enzalutamide, Pralatrexate, Irinotecan Liposomal, Marqibo

Does Study Claim a Cure? Beware of Scientific 'Spin'

Posted 12 days ago by Drugs.com

MONDAY, Sept. 11, 2017 – Take with a grain of salt any flashy reports from clinical trials boasting groundbreaking results, a new scientific review warns. A majority of clinical trials published in medical journals hype their findings, presenting them in a way that makes them look more favorable than they actually are, said senior researcher Lisa Bero. An evidence review conducted by Bero and her colleagues found more than half of clinical trials "spin" their results either in the abstracts (summaries) or the main text of the published report. "'Breakthrough' studies are quite rare, so any study making bold claims about [effectiveness] or causality should be viewed skeptically," said Bero, who's chair of medicines use and health outcomes with the University of Sydney in Australia. "Science is an accumulation of knowledge, so new studies need to be put in the context of others," she ... Read more

Related support groups: Cancer, Prevention of Cardiovascular Disease, Cardiovascular Risk Reduction

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Breast Cancer, Prostate Cancer, Colorectal Cancer, Renal Cell Carcinoma, Ovarian Cancer, Brain Tumor, Skin Cancer, Head and Neck Cancer, Pancreatic Cancer, view more... Bladder Cancer, Endometrial Cancer, Cervical Cancer, Hypercalcemia of Malignancy, Lung Cancer, Soft Tissue Sarcoma, Testicular Cancer, Stomach Cancer, Osteosarcoma, Neuroendocrine Carcinoma, Gastric Cancer, Solid Tumors, Urinary Tract Tumors, Adrenal Cortical Carcinoma, Peritoneal Cancer, Fallopian Tube Cancer, Malignant Pleural Mesothelioma, Neuroblastoma, Ewing's Sarcoma, Malignant Pleural Effusion, Choriocarcinoma, Tumor Lysis Syndrome, Multicentric Castleman’s Disease, Urinary Tract Cancer

Related Drug Support Groups

fluorouracil, carboplatin, Cytoxan, cyclophosphamide, doxorubicin, Adriamycin, Leukeran, vincristine, vinblastine, view more... chaparral, Hycamtin, etoposide, topotecan, amifostine, Velban, Mustargen, Neosar, thiotepa, levamisole, Oncovin, chlorambucil, Fludara, Adrucil, fludarabine, Ethyol, Cytoxan Lyophilized, Adriamycin PFS, Thioplex, Ergamisol, Adriamycin RDF, Carboplatin Novaplus, Ifex, Vincasar PFS, dactinomycin, Paraplatin, Toposar, Etopophos, VePesid, ifosfamide, Cosmegen, mechlorethamine, Tepadina